Key facts
- James & Ella’s last known valuation is $9.2M (Feb 2026).
- It has raised $3.2M; the latest was Later Stage VC ($1.8M) in Feb 2026.
- Notable investors include Leap Venture Studio, Yuyu Pharma.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for James & Ella
- ·The full record, as it builds
Funding rounds
No funding rounds for James & Ella are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About James & Ella
Producer of pet food products intended for animal consumption. The company provides freeze-dried raw and raw-hybrid dog food, meals for dogs, while also fostering a supportive community for pet parents and contributing to animal welfare through charitable partnerships, enabling pet owners to prioritize their dogs' health and well-being.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Dorset, United Kingdom
- Founded
- 2019
- Employees
- 10
- Website
- ella.co/
- Ownership
- Privately Held (backing)
James & Ella doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in James & Ella shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on James & Ella in its N-PORT filings yet. We sweep new filings monthly.